US Stock MarketDetailed Quotes

Neuphoria Therapeutics (NEUP)

Watchlist
  • 5.040
  • +0.130+2.65%
Close Apr 24 16:00 ET
  • 5.040
  • 0.0000.00%
Post 20:01 ET
27.17MMarket Cap2.96P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neuphoria Therapeutics (NEUP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-91.65%-6.44M
14.40%-3.79M
100.53%77.23K
-19.07%-3.59M
447.59%11.45M
14.88%-3.36M
-0.07%-4.43M
-0.29%-14.68M
-3.01M
-3.3M
Net income from continuing operations
195.92%1.86M
-1,130.95%-9.91M
97.61%-369.63K
-230.61%-8.88M
505.38%11.26M
57.33%-1.94M
85.29%-804.79K
27.54%-15.49M
---2.69M
---2.78M
Operating gains losses
-269.61%-5.16M
261.84%4.42M
-94.90%-713.99K
731.09%2.69M
446.38%724.04K
-791.81%-1.39M
-4,160.07%-2.73M
34.21%-366.33K
---426.23K
---209.03K
Depreciation and amortization
-0.20%165.79K
0.05%165.79K
-0.02%662.89K
-0.04%165.63K
-0.16%165.43K
0.26%166.12K
-0.12%165.71K
-0.03%662.99K
--165.69K
--165.7K
Other non cash items
-33.89%81.29K
-86.83%14.63K
139.77%697.94K
122.21%539.24K
-112.26%-75.35K
219.80%122.97K
-30.89%111.08K
-347.96%-1.75M
---2.43M
--614.83K
Change In working capital
-962.15%-3.49M
216.53%1.4M
-125.00%-363.75K
-20.00%1.81M
41.90%-642.52K
-54.55%-328.16K
-332.25%-1.2M
-68.27%1.45M
--2.26M
---1.11M
-Change in receivables
-1,478.31%-1.11M
-6.72%10.19K
-61.59%114.94K
159.71%12.64K
13.79%10.97K
-75.41%80.4K
167.22%10.92K
-92.77%299.2K
---21.18K
--9.64K
-Change in prepaid assets
-8.12%195.37K
127.48%517.87K
-233.76%-453.06K
-610.73%-890.93K
-100.81%-2.43K
137.70%212.64K
-46.72%227.66K
94.69%338.71K
--174.44K
--301K
-Change in payables and accrued expense
-321.65%-2.45M
172.72%934.62K
-47.42%568.99K
31.61%2.85M
69.41%-409.8K
-794.20%-581.71K
-830.80%-1.29M
111.27%1.08M
--2.16M
---1.34M
-Change in other current liabilities
-66.79%-85.21K
-57.75%-31.1K
-0.06%-126.19K
-19.33%-28.39K
35.69%-26.99K
-110.35%-51.09K
45.32%-19.72K
-26.41%-126.11K
---23.79K
---41.97K
-Change in other working capital
-400.02%-34.79K
73.68%-34.79K
-236.58%-468.43K
-283.82%-133.54K
-515.81%-214.26K
133.33%11.6K
-280.01%-132.22K
0.00%-139.17K
---34.79K
---34.79K
Cash from discontinued investing activities
Operating cash flow
-91.65%-6.44M
14.40%-3.79M
100.53%77.23K
-19.07%-3.59M
447.59%11.45M
14.88%-3.36M
-0.07%-4.43M
-0.29%-14.68M
---3.01M
---3.3M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
13,242.71%14.66M
1,531.18%3.25M
-89.88%1.53M
-90.11%704.68K
-33.51%1.16M
-101.98%-111.56K
-137.11%-227.34K
291.58%15.11M
54,032.75%7.12M
950.82%1.75M
Net common stock issuance
--14.66M
--3.25M
-84.89%1.53M
-66.83%704.68K
-42.68%823.6K
--0
--0
162.07%10.11M
--2.12M
--1.44M
Proceeds from stock option exercised by employees
----
--0
--0
----
----
----
--409
--5M
----
----
Net other financing activities
----
----
----
----
----
-102.08%-111.15K
95.97%-227.75K
----
----
----
Cash from discontinued financing activities
Financing cash flow
13,242.71%14.66M
1,531.18%3.25M
-89.88%1.53M
-90.11%704.68K
-33.51%1.16M
-101.98%-111.56K
-137.11%-227.34K
291.58%15.11M
54,032.75%7.12M
950.82%1.75M
Net cash flow
Beginning cash position
68.14%13.73M
12.63%14.29M
4.15%12.69M
101.32%17.12M
-56.83%4.42M
-0.57%8.16M
4.15%12.69M
-47.50%12.18M
-43.59%8.5M
-50.35%10.24M
Current changes in cash
337.10%8.23M
88.39%-541.03K
275.10%1.61M
-170.07%-2.88M
915.67%12.62M
-306.38%-3.47M
-22.09%-4.66M
103.97%428.02K
224.88%4.11M
72.08%-1.55M
Effect of exchange rate changes
206.76%295.41K
-114.06%-19.46K
-104.87%-3.75K
-31.45%49.61K
145.72%84.97K
-180.61%-276.69K
190.57%138.37K
131.57%76.97K
130.02%72.37K
-27,577.08%-185.86K
End cash Position
403.56%22.25M
68.14%13.73M
12.63%14.29M
12.63%14.29M
101.32%17.12M
-56.83%4.42M
-0.57%8.16M
4.15%12.69M
4.15%12.69M
-43.59%8.5M
Free cash flow
-91.65%-6.44M
14.40%-3.79M
100.53%77.23K
-19.07%-3.59M
447.59%11.45M
14.88%-3.36M
-0.07%-4.43M
-0.29%-14.68M
5.17%-3.01M
38.23%-3.3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -91.65%-6.44M14.40%-3.79M100.53%77.23K-19.07%-3.59M447.59%11.45M14.88%-3.36M-0.07%-4.43M-0.29%-14.68M-3.01M-3.3M
Net income from continuing operations 195.92%1.86M-1,130.95%-9.91M97.61%-369.63K-230.61%-8.88M505.38%11.26M57.33%-1.94M85.29%-804.79K27.54%-15.49M---2.69M---2.78M
Operating gains losses -269.61%-5.16M261.84%4.42M-94.90%-713.99K731.09%2.69M446.38%724.04K-791.81%-1.39M-4,160.07%-2.73M34.21%-366.33K---426.23K---209.03K
Depreciation and amortization -0.20%165.79K0.05%165.79K-0.02%662.89K-0.04%165.63K-0.16%165.43K0.26%166.12K-0.12%165.71K-0.03%662.99K--165.69K--165.7K
Other non cash items -33.89%81.29K-86.83%14.63K139.77%697.94K122.21%539.24K-112.26%-75.35K219.80%122.97K-30.89%111.08K-347.96%-1.75M---2.43M--614.83K
Change In working capital -962.15%-3.49M216.53%1.4M-125.00%-363.75K-20.00%1.81M41.90%-642.52K-54.55%-328.16K-332.25%-1.2M-68.27%1.45M--2.26M---1.11M
-Change in receivables -1,478.31%-1.11M-6.72%10.19K-61.59%114.94K159.71%12.64K13.79%10.97K-75.41%80.4K167.22%10.92K-92.77%299.2K---21.18K--9.64K
-Change in prepaid assets -8.12%195.37K127.48%517.87K-233.76%-453.06K-610.73%-890.93K-100.81%-2.43K137.70%212.64K-46.72%227.66K94.69%338.71K--174.44K--301K
-Change in payables and accrued expense -321.65%-2.45M172.72%934.62K-47.42%568.99K31.61%2.85M69.41%-409.8K-794.20%-581.71K-830.80%-1.29M111.27%1.08M--2.16M---1.34M
-Change in other current liabilities -66.79%-85.21K-57.75%-31.1K-0.06%-126.19K-19.33%-28.39K35.69%-26.99K-110.35%-51.09K45.32%-19.72K-26.41%-126.11K---23.79K---41.97K
-Change in other working capital -400.02%-34.79K73.68%-34.79K-236.58%-468.43K-283.82%-133.54K-515.81%-214.26K133.33%11.6K-280.01%-132.22K0.00%-139.17K---34.79K---34.79K
Cash from discontinued investing activities
Operating cash flow -91.65%-6.44M14.40%-3.79M100.53%77.23K-19.07%-3.59M447.59%11.45M14.88%-3.36M-0.07%-4.43M-0.29%-14.68M---3.01M---3.3M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 13,242.71%14.66M1,531.18%3.25M-89.88%1.53M-90.11%704.68K-33.51%1.16M-101.98%-111.56K-137.11%-227.34K291.58%15.11M54,032.75%7.12M950.82%1.75M
Net common stock issuance --14.66M--3.25M-84.89%1.53M-66.83%704.68K-42.68%823.6K--0--0162.07%10.11M--2.12M--1.44M
Proceeds from stock option exercised by employees ------0--0--------------409--5M--------
Net other financing activities ---------------------102.08%-111.15K95.97%-227.75K------------
Cash from discontinued financing activities
Financing cash flow 13,242.71%14.66M1,531.18%3.25M-89.88%1.53M-90.11%704.68K-33.51%1.16M-101.98%-111.56K-137.11%-227.34K291.58%15.11M54,032.75%7.12M950.82%1.75M
Net cash flow
Beginning cash position 68.14%13.73M12.63%14.29M4.15%12.69M101.32%17.12M-56.83%4.42M-0.57%8.16M4.15%12.69M-47.50%12.18M-43.59%8.5M-50.35%10.24M
Current changes in cash 337.10%8.23M88.39%-541.03K275.10%1.61M-170.07%-2.88M915.67%12.62M-306.38%-3.47M-22.09%-4.66M103.97%428.02K224.88%4.11M72.08%-1.55M
Effect of exchange rate changes 206.76%295.41K-114.06%-19.46K-104.87%-3.75K-31.45%49.61K145.72%84.97K-180.61%-276.69K190.57%138.37K131.57%76.97K130.02%72.37K-27,577.08%-185.86K
End cash Position 403.56%22.25M68.14%13.73M12.63%14.29M12.63%14.29M101.32%17.12M-56.83%4.42M-0.57%8.16M4.15%12.69M4.15%12.69M-43.59%8.5M
Free cash flow -91.65%-6.44M14.40%-3.79M100.53%77.23K-19.07%-3.59M447.59%11.45M14.88%-3.36M-0.07%-4.43M-0.29%-14.68M5.17%-3.01M38.23%-3.3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -